Immune cell function assay and T lymphocyte counts lack association with rejection or infection in pediatric heart transplant recipients.

No association was found between these immune markers and adverse outcomes. In the absence of larger pediatric studies justifying the role of these tests in identifying elevated risk profiles post OHT, we do not recommend their routine use.